Waters Corp, US9418481035

Waters stock climbs after earnings beat and guidance lift

Published on 08/20/2026 at 13:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Waters stock climbed after a second-quarter beat on August 4, 2026, with revenue, EPS and full-year guidance all moving higher.

Schwarzweiß-Reportage: Techniker an chromatographischem Analysegerät im Labor
Waters Corporation (ISIN US9418481035) dokumentiert in Schwarzweiß einen Techniker an chromatographischen Analysegeräten im Labor, Illustration mit AI erstellt.

Waters Corp (US9418481035) stock climbed to $416.45 on August 19, 2026, after the company said second-quarter revenue reached $1.65 billion and adjusted EPS came in at $3.05. The move followed a session that ended at $416.45, up $15.20 or 3.79%, with after-hours trading at $415.96.

Earnings beat lands

The latest reported quarter showed revenue of $1.65 billion versus $1.62 billion expected, while EPS of $3.05 beat the $3.01 consensus by $0.04. The same update lifted 2026 adjusted EPS guidance to $14.45-$14.65 and organic growth to 7%-9%, giving the stock a fresh earnings anchor for August 2026.

That matters because the market is now trading Waters against a high bar: the shares finished the session at $416.45, the 52-week range stretched from $282.77 to $420.26, and market capitalization stood at $40.92 billion. The current setup leaves less room for disappointment after a quarter that also showed a 113.3% year-over-year revenue increase on MarketBeat's earnings summary.

Consensus stays firm

Brokerage coverage still points to a Moderate Buy view, with a consensus price target of $420.35 and 20 analysts tracked on the page. The implied gap is narrow, and the average target sits just 0.9% above the quoted share price, which makes execution on the new guidance range more important than a broad valuation rerating.

Waters also remains a classic tools-and-consumables story. Its analytical instruments, chromatography systems and mass spectrometry platforms support pharma, biotech, clinical and environmental labs, so recurring service and consumables demand can soften swings in instrument sales.

Product line pressure

In practice, that means the company's chromatography and mass spectrometry portfolio carries much of the commercial weight. Those systems help laboratories separate, identify and quantify compounds, which is why usage in regulated testing and drug development can feed both replacement demand and recurring support revenue.

As a stock, Waters closed at $416.45 on August 19, 2026, with extended trading at $415.96. The share price sat close to its 52-week high of $420.26 and above the 50-day range floor of $355.10.

Company facts

Company: Waters Corp
ISIN: US9418481035
Ticker: WAT
Exchange: NYSE
Sector / Industry: Healthcare / Life Sciences Tools & Services
Index membership: S&P 500
Price (as of August 19, 2026, 3:59 p.m. ET): $416.45 USD
Market cap: $40.92 billion (as of August 19, 2026)
Next earnings date: November 3, 2026

Disclaimer...

en | US9418481035 | WATERS CORP | boerse | 69975663 | bgmi